Ohr Pharmaceutical Inc. | Income Statement
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
91.10
466.30
1,179.30
1,189.30
1,165.70
1,124.60
Gross Income
91.10
466.30
1,179.30
1,189.30
1,165.70
1,124.60
SG&A Expense
4,529.80
8,656.60
16,287.10
24,117.00
22,685.10
7,953.60
EBIT
4,620.90
9,122.90
17,466.40
25,306.30
23,780.10
7,849.40
Unusual Expense
1,117.60
-
2,298.90
475.40
-
5,904.60
Non Operating Income/Expense
90.80
8.50
78.80
3.40
1.40
442.60
Interest Expense
4.70
5.60
6.00
-
29.60
-
Pretax Income
5,652.50
9,130.70
15,197.90
25,766.20
23,811.00
13,236.90
Consolidated Net Income
5,652.50
9,130.70
15,197.90
25,766.20
23,811.00
13,236.90
Net Income
5,652.50
9,130.70
15,197.90
25,766.20
23,811.00
13,236.90
Net Income After Extraordinaries
5,652.50
9,130.70
15,197.90
25,766.20
23,811.00
13,236.90
Net Income Available to Common
5,652.50
9,130.70
15,197.90
25,766.20
23,811.00
13,236.90
EPS (Basic)
0.30
0.41
0.54
0.82
0.53
4.69
Basic Shares Outstanding
18,707.80
22,141.50
28,404.40
31,349.20
44,770.70
2,820
EPS (Diluted)
0.30
0.41
0.54
0.82
0.53
4.69
Diluted Shares Outstanding
18,707.80
22,141.50
28,404.40
31,349.20
44,770.70
2,820
EBITDA
4,529.80
8,656.60
16,287.10
24,117.00
22,614.40
6,724.80
Other Operating Expense
-
-
-
-
70.80
1,228.80
Non-Operating Interest Income
-
-
-
12.10
-
74.50
Equity in Affiliates (Pretax)
-
10.60
103.10
-
-
-
About Ohr Pharmaceutical
View Profile
